Skip to content

Amphotericin b

Abelcet, Ambisome, Amphotec, Fungizone (amphotericin b) is a small molecule pharmaceutical. Amphotericin b was first approved as Abelcet on 1982-01-01. It is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, and coccidioidomycosis amongst others in the USA.
Trade Name Abelcet, Ambisome, Amphotec, Fungizone
Common Name Amphotericin b
Indication aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, coccidioidomycosis, cryptococcal meningitis, cutaneous candidiasis, cystitis, fungemia, histoplasmosis, mycoses, neutropenia, paracoccidioidomycosis, peritonitis, sporotrichosis, urinary tract infections, visceral leishmaniasis, zygomycosis
Drug Class
Amphotericin b
Get full access now